Literature DB >> 10528932

Distribution of epilepsy syndromes in a cohort of children prospectively monitored from the time of their first unprovoked seizure.

S Shinnar1, C O'Dell, A T Berg.   

Abstract

PURPOSE: To assess the distribution of epilepsy syndromes and their stability in children.
METHODS: A cohort of 407 children with a first unprovoked seizure was prospectively recruited and followed up for a mean of 9.4 years. Etiology and epilepsy syndromes were classified by using the International League Against Epilepsy (ILAE) guidelines in the 182 children with two or more seizures. Classification was done both at time of second seizure and at last follow-up. Two-year terminal remission also was analyzed by etiology and epilepsy syndrome.
RESULTS: Etiology of epilepsy syndromes was idiopathic in 45 (25%), cryptogenic in 89 (49%), and remote symptomatic in 48 (26%). In the initial classification, 114 (63%) children had a localization-based epilepsy syndrome including idiopathic in 26, cryptogenic in 34, and symptomatic based on localization or etiology in 54. Twenty-one (12%) children had a generalized epilepsy syndrome, including 19 with primary generalized epilepsy. Forty-seven (26%) cases were in the category of undetermined if focal or generalized. At last follow-up, there was a change in either etiology (n = 16) or the final epilepsy syndrome classification (n = 33) or both (n = 15) in 34 (19%) cases. At time of last follow-up, 144 (79%) of the children with epilepsy were in 2-year terminal remission, and 108 (59%) were in 2-year terminal remission without medications. Factors associated with a favorable prognosis included an idiopathic or cryptogenic etiology and having a localization-based idiopathic epilepsy syndrome.
CONCLUSIONS: After two seizures, childhood-onset epilepsy can be classified by etiology and epilepsy syndrome. Prognosis is favorable in the majority of cases. However, the apparent syndrome may change with longer follow-up. The ability to classify these cases early in the clinical course is important if they are to be used for prognostic purposes.

Entities:  

Mesh:

Year:  1999        PMID: 10528932     DOI: 10.1111/j.1528-1157.1999.tb02008.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  19 in total

1.  Epidemiology in Epilepsy.

Authors:  Anne T. Berg
Journal:  Epilepsy Curr       Date:  2001-11       Impact factor: 7.500

Review 2.  The state of the art in the genetic analysis of the epilepsies.

Authors:  David A Greenberg; Deb K Pal
Journal:  Curr Neurol Neurosci Rep       Date:  2007-07       Impact factor: 5.081

3.  High risk of reading disability and speech sound disorder in rolandic epilepsy families: case-control study.

Authors:  Tara Clarke; Lisa J Strug; Peregrine L Murphy; Bhavna Bali; Janessa Carvalho; Suzanne Foster; Geoffrey Tremont; Bernadine R Gagnon; Nelson Dorta; Deb K Pal
Journal:  Epilepsia       Date:  2007-09-10       Impact factor: 5.864

4.  Cognitive outcomes in children who present with a first unprovoked seizure.

Authors:  Yoshimi Sogawa; David Masur; Christine O'Dell; Solomon L Moshe; Shlomo Shinnar
Journal:  Epilepsia       Date:  2010-09-24       Impact factor: 5.864

5.  Inter-rater agreement for diagnoses of epilepsy in pregnant women.

Authors:  Shahram Khoshbin; Amy Herring; Gregory L Holmes; Donald Schomer; Daniel Hoch; Elizabeth C Dooling; Eileen P G Vining; Lewis B Holmes
Journal:  Epilepsy Behav       Date:  2013-02-15       Impact factor: 2.937

6.  Neuroimaging in the definition and organization of the epilepsies: we're not there yet.

Authors:  Jason S Hauptman; Noriko Salamon; Gary W Mathern
Journal:  Epilepsia       Date:  2012-07       Impact factor: 5.864

7.  Centrotemporal sharp wave EEG trait in rolandic epilepsy maps to Elongator Protein Complex 4 (ELP4).

Authors:  Lisa J Strug; Tara Clarke; Theodore Chiang; Minchen Chien; Zeynep Baskurt; Weili Li; Ruslan Dorfman; Bhavna Bali; Elaine Wirrell; Steven L Kugler; David E Mandelbaum; Steven M Wolf; Patricia McGoldrick; Huntley Hardison; Edward J Novotny; Jingyue Ju; David A Greenberg; James J Russo; Deb K Pal
Journal:  Eur J Hum Genet       Date:  2009-01-28       Impact factor: 4.246

8.  Diagnosis switching and outcomes in a cohort of patients with potential epilepsy with myoclonic-atonic seizures.

Authors:  Krista Eschbach; Angela Moss; Charuta Joshi; Katie Angione; Garnett Smith; Amanda Dempsey; Elizabeth Juarez-Colunga; Scott T Demarest
Journal:  Epilepsy Res       Date:  2018-09-24       Impact factor: 3.045

9.  Diagnoses made in a secondary care "fits, faints, and funny turns" clinic.

Authors:  D Hindley; A Ali; C Robson
Journal:  Arch Dis Child       Date:  2006-03       Impact factor: 3.791

10.  Seizure suppression by high frequency optogenetic stimulation using in vitro and in vivo animal models of epilepsy.

Authors:  Chia-Chu Chiang; Thomas P Ladas; Luis E Gonzalez-Reyes; Dominique M Durand
Journal:  Brain Stimul       Date:  2014-07-19       Impact factor: 8.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.